Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Invitrogen buys Applied Biosystems for $6.3bn

Executive Summary

Invitrogen is buying Applera's Applied Biosystems Group for $6.3bn. Holders of Applera-Applied Biosystems common stock will receive $38 (a 12% premium and contingent upon Invitrogen's share price when the transaction closes) in Invitrogen stock and cash for each share they own. (Invitrogen estimates a split between cash and stock of 45% and 55%, respectively).
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Genomics-Proteomics
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
    • PCR & Amplification Tools
Deal Status
  • Final
Deal Type
  • Acquisition
    • Payment Includes Cash
    • Full Acquisition
    • Reverse Acquisition
    • Payment Includes Stock
    • Includes Contract
    • Intra-Biotech Deal
UsernamePublicRestriction

Register